Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
JENTADUETO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use JENTADUETO XR is not recommended in patients with type 1 diabetes mellitus. JENTADUETO XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO XR [see Warnings and Precautions (5.2)].
- generic_name
- linagliptin and metformin hydrochloride
- product_names
- linagliptin and metformin hydrochloride
- ndc
- 0597-0270, 0597-0270-12, 0597-0270-73, 0597-0270-94, 0597-0275, 0597-0275-33, 0597-0275-81, 0597-0275-88
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en